(Q44241571)

1 December 2017

Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype (English)

1 reference

Heather Spencer Feigelson

1 December 2017

series ordinal

2

object named as

Heather Spencer Feigelson

1 reference

1 December 2017

1

Eugenia E Calle

1 reference

1 December 2017

5

Michael J Thun

1 reference

1 December 2017

Janet S Hildebrand

3

1 reference

1 December 2017

Lauren R Teras

series ordinal

4

1 reference

1 December 2017

Carmen Rodriguez

series ordinal

6

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

1 December 2017

1 reference

1 December 2017

115

1 reference

1 December 2017

5

1 reference

1 December 2017

936-945

1 reference

Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries

1 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

Progestins and progesterone in hormone replacement therapy and the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

Postmenopausal hormone therapy and breast cancer risk: the Multiethnic Cohort

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

Dual effects of weight and weight gain on breast cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

Redundancy of single diagnostic test evaluation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24101

7 January 2021

Identifiers

DOI

10.1002/CNCR.24101

1 reference

1 December 2017

1 reference